Ganglionic Stimulants

• 

  Subject Areas on Research

  • Brain indices of nicotine's effects on attentional bias to smoking and emotional pictures and to task-relevant targets. 
  • Challenges and solutions for recruiting pregnant smokers into a nicotine replacement therapy trial. 
  • Chronic exposure to nicotine does not prevent neurocognitive decline after cardiac surgery. 
  • Effects of low nicotine content cigarettes on smoke intake. 
  • Effects of nicotine on brain responses to emotional pictures. 
  • Effects of quitting smoking on EEG activation and attention last for more than 31 days and are more severe with stress, dependence, DRD2 A1 allele, and depressive traits. 
  • Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. 
  • Fetal nicotine or cocaine exposure: which one is worse? 
  • Guidelines on nicotine dose selection for in vivo research. 
  • Human functional neuroimaging in nicotine and tobacco research: basics, background, and beyond. 
  • In vivo regulation of [3H]acetylcholine recognition sites in brain by nicotinic cholinergic drugs. 
  • Increased expression of glial fibrillary acidic protein in cerebellum and hippocampus: differential effects on neonatal brain regional acetylcholinesterase following maternal exposure to combined chlorpyrifos and nicotine. 
  • Maternal tobacco smoking, nicotine replacement and neurobehavioural development. 
  • Oxidative mechanisms contributing to the developmental neurotoxicity of nicotine and chlorpyrifos. 
  • Radial-arm maze performance in rats is impaired by a combination of nicotinic-cholinergic and D2 dopaminergic antagonist drugs. 
  • Safety and effectiveness of transdermal nicotine patch in smokers admitted with acute coronary syndromes. 
  • Sex-selective hippocampal alterations after adolescent nicotine administration: effects on neurospecific proteins. 
  • Short-term adolescent nicotine exposure in rats elicits immediate and delayed deficits in T-lymphocyte function: critical periods, patterns of exposure, dose thresholds. 
  • The effects of nicotine and non-nicotine smoking factors on working memory and associated brain function. 
  • The effects of nicotine on vascular smooth muscle cell chemotaxis induced by thrombospondin-1 and fibronectin. 
  • The long-term effects of prenatal nicotine exposure on neurologic development. 
• 

  Keywords of People

  • Schwartz-Bloom, Rochelle D., Professor Emeritus of Pharmacology & Cancer Biology, Duke Science & Society